3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
246
Leukemia
185
Lymphoma
137
Leukemia, Myeloid, Acute
103
Burkitt Lymphoma
90
Myelodysplastic Syndromes
79
Lymphoma, Non-Hodgkin
65
Lymphoma, Large B-Cell, Diffuse
59
Breast Neoplasms
59
Leukemia, Lymphocytic, Chronic, B-Cell
49
Lymphoma, Mantle-Cell
47
Hodgkin Disease
47
Graft vs Host Disease
46
Lymphoma, Follicular
45
Leukemia, Myeloid, Accelerated Phase
45
Multiple Myeloma
39
Leukemia, Myeloid, Chronic-Phase
39
Congenital Abnormalities
39
Myeloproliferative Disorders
38
Blast Crisis
38
Leukemia, Myelomonocytic, Chronic
37
Leukemia, Biphenotypic, Acute
35
Recurrence
34
Lymphoma, Large-Cell, Immunoblastic
33
Lymphoma, B-Cell, Marginal Zone
31
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
30
Primary Myelofibrosis
27
Osteosarcoma
27
Neoplasms, Plasma Cell
25
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
25
Interventions
pembrolizumab
162
Carboplatin
144
Paclitaxel
125
Cyclophosphamide
93
130-nm albumin-bound paclitaxel
66
Capecitabine
63
Gemcitabine
54
Doxorubicin
49
Albumin-Bound Paclitaxel
45
Taxes
42
atezolizumab
40
Cisplatin
38
Nivolumab
34
sacituzumab govitecan
32
olaparib
32
Epirubicin
32
Docetaxel
28
eribulin
27
Specimen Handling
26
Bevacizumab
26
durvalumab
25
camrelizumab
23
Drug Therapy
22
Biopsy
22
Magnetic Resonance Spectroscopy
21
toripalimab
18
Radiotherapy
17
spartalizumab
16
Everolimus
15
fludarabine
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Triple Negative Breast Neoplasms
×
Methotrexate
×
Clear all
NCT00022516
2016-09-16
22-00
ETOP IBCSG Partners Foundation
Phase 3
Completed
1,086 enrolled
10 charts